Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caribou Biosciences, Inc. - CRBU


NEW YORK, June 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Caribou Biosciences, Inc. ("Caribou" or the "Company") (NASDAQ: CRBU). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Caribou and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On June 2, 2024, Caribou issued a press release announcing that the Company had "presented updated clinical data from the ongoing ANTLER Phase 1 trial that indicates a single dose of CB-010, a readily available, off-the-shelf anti-CD19 CAR-T cell therapy with a PD-1 knockout, has the potential to rival the safety, efficacy, and durability of approved autologous CAR-T cell therapies." Following Caribou's announcement, Evercore analysts downgraded the stock to "in line" and dropped its price target to $3.00 from $13.00, stating that they were "not yet convinced" that Caribou's therapy "will be competitive and wait on the sidelines until data in 1H 2025." 

On this news, Caribou's stock price fell $0.734 per share, or 15.52%, to close at $2.145 per share on June 3, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 03:16
As it prepares to host its' annual Access Bank Polo Day at Guards Polo Club Windsor on Saturday 20 July The Access Bank UK Limited has posted...

at 03:05
Woodward, Inc. , a global leader in energy control solutions for aerospace and industrial applications, announced it has been selected to provide rotary actuation solutions for the NASA and Boeing Transonic Truss-braced Wing (TTBW) X-66A aircraft...

at 03:01
The Goodyear Tire & Rubber Company ("Goodyear" or the "Company") today announced that it has signed a definitive agreement to sell its Off-the-Road ("OTR") tire business to The Yokohama Rubber Company, Limited (TYO: 5101) ("Yokohama") for $905...

at 03:00
GA Telesis, a global leader in aerospace ecosystem solutions, and Alitheon, a pioneer in optical AI for no-touch serialization, have joined forces to integrate Alitheon's cutting-edge optical AI technology, FeaturePrint®, into WILBUR, GA Telesis's...

at 03:00
JPA Health, an independent, full-service agency working exclusively in the health sector, announced the acquisition of London-based akt health, an award-winning communications agency recognized for its work in delivering excellence across public...

at 03:00
FinVolution Group ("FinVolution," or the "Company") , a leading fintech platform, today announced it has released its 2023 Environmental, Social, and Governance (ESG) report, the Company's sixth consecutive annual ESG report. The report provides a...



News published on and distributed by: